Lv4
480 积分 2024-08-05 加入
Role of the gut microbiota in the pathogenesis of IgA nephropathy
1个月前
已完结
Serum uric acid, body mass index, and cardiovascular diseases: A multiple two-step Mendelian randomization study
1个月前
已完结
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
1个月前
已完结
Attribute-based medicine for IgA nephropathy: risk factor constellations influence kidney prognosis
1个月前
已完结
Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
1个月前
已完结
IgA nephropathy
1个月前
已完结
Expert consensus for the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2025 update
1个月前
已完结
Dual Mechanisms of Hyperuricemia‐Associated Renal Injury: A Systematic Review of Crystal‐Dependent and Crystal‐Independent Pathways
1个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
2个月前
已完结
Biopsy-proven glomerular diseases: a systematic review of global kidney biopsy registries
2个月前
已完结
皖公网安备34019202002308
